¼¼°èÀÇ ÀÇ·á µî±Þ Á¾ÀÌ ½ÃÀå
Medical Grade Papers
»óǰÄÚµå : 1797368
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 378 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÇ·á µî±Þ Á¾ÀÌ ½ÃÀåÀº 2030³â±îÁö 56¾ï ´Þ·¯¿¡ µµ´Þ

¼¼°èÀÇ ÀÇ·á µî±Þ Á¾ÀÌ ½ÃÀåÀº 2024³â¿¡ 47¾ï ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024-2030³â¿¡ CAGR 3.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 56¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÄÚÆÃÁö´Â CAGR 3.7%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 38¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñµµ°øÁö ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 1.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 13¾ï ´Þ·¯, Áß±¹Àº CAGR 5.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÇ·á µî±Þ Á¾ÀÌ ½ÃÀåÀº 2024³â¿¡ 13¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 11¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ Áß(2022-2030³â) CAGRÀº 5.9%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.1%¿Í 2.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀÇ·á µî±Þ Á¾ÀÌ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÇ·á¿ë Á¾À̰¡ Àüü ÀÇ·á ºÐ¾ß¿¡¼­ Àü·«Àû Á߿伺ÀÌ ³ô¾ÆÁö´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÀÇ·á¿ë Á¾ÀÌ´Â º´¿ø, Áø´Ü ½ÇÇè½Ç, ÀÇ·á±â±â Á¦Á¶ ȯ°æ¿¡¼­ ¹«±Õ Æ÷Àå, ¶óº§¸µ, ¹®¼­È­ °úÁ¤¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ Á¾ÀÌ´Â ´Ù°ø¼º, ¹«°á¼º, À庮¼ºÀ» À¯ÁöÇϸ鼭 ¿ÀÅäŬ·¹ÀÌºê ¸ê±Õ, °¨¸¶¼± ¸ê±Õ, ¿¡Æ¿·»¿Á»çÀÌµå ¸ê±ÕÀ» °ßµô ¼ö ÀÖµµ·Ï Ưº°È÷ ¼³°èµÇ¾ú½À´Ï´Ù. ÁÖ·Î ¼ö¼ú±â±¸, »óó °ü¸® Á¦Ç°, ÁÖ»ç±â, Ä«Å×ÅÍ, Ä«Å×ÅÍ, °Ë»ç ŰƮ, ÀÏȸ¿ë ±â±â µîÀÇ Æ÷ÀåÀç·Î »ç¿ëµÇ¾î »ç¿ë ½ÃÁ¡±îÁö ¹«±Õ¼ºÀ» º¸ÀåÇÕ´Ï´Ù.

ÀÇ·á¿ë Á¾À̸¦ »ç¿ëÇÑ ¹«±Õ ¹è¸®¾î ½Ã½ºÅÛÀº ÀÇ·áǰ º¸°ü ¹× ¿î¼Û Áß ¹Ì»ý¹°ÀÇ Ä§ÀÔ°ú ÀÔÀÚ ¿À¿°À» ¹æÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ¿­Á¢Âø, Á¢ÂøÁ¦ Á¢Âø, ÃÊÀ½ÆÄ ¿ëÁ¢ µî ´Ù¾çÇÑ ½Ç¸µ ±â¼ú¿¡ ÀûÇÕÇϹǷΠForm Fill Seal¸µ Æ÷Àå ¶óÀο¡ ÇʼöÀûÀÎ ÀåºñÀÔ´Ï´Ù. ÀÇ·á °ü·Ã °¨¿°(HAI) ¹× ¿À¿° À§ÇèÀÌ ½É°¢ÇÏ°Ô ´ëµÎµÇ´Â ½Ã´ë¿¡ ÀÇ·á¿ëÁö´Â °¨¿° °ü¸® ÇÁ·ÎÅäÄÝÀÇ ±âº» ±¸¼º ¿ä¼Ò·Î ¿ì¼±¼øÀ§¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

¾î¶² ±â¼úÀû Ư¡°ú Çõ½ÅÀÌ ÀÇ·á¿ëÁöÀÇ ¼º´ÉÀ» Çâ»ó½Ã۴°¡?

Á¦Áö È­ÇÐ, ¼¶À¯ ±â¼ú, ÄÚÆÃ ¹èÇÕÀÇ ¹ßÀüÀ¸·Î ÀÇ·á¿ë Á¾ÀÌÀÇ ¼º´É Ư¼ºÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. °í°­µµ ¼¿·ê·Î¿À½º ¼¶À¯´Â Á¾Á¾ ÇÕ¼º º¸°­Àç¿Í È¥ÇÕµÇ¾î ¹Ú¸® ¹× º¯»ö ¾øÀÌ ¸ê±Õ »çÀÌŬÀ» °ßµô ¼ö ÀÖ°í, Âõ¾îÁöÁö ¾Ê°í, Âõ¾îÁöÁö ¾ÊÀ¸¸ç, ¸°ÆÃÀÌ ÀûÀº ±âÆÇÀ» ¸¸µå´Â µ¥ »ç¿ëµË´Ï´Ù. Á¦Á¶¾÷ü´Â EN868, ISO11607, ASTM F88 µî ±¹Á¦ Ç¥ÁØ¿¡ ºÎÇÕÇϵµ·Ï Æò·®, Åë±â¼º, ¹Ì»ý¹° Â÷´Ü È¿°ú¸¦ ÃÖÀûÈ­Çϰí ÀÖ½À´Ï´Ù.

Æú¸®¿¡Æ¿·», ¾ÆÅ©¸±·¹ÀÌÆ®, ½Ç¸®ÄÜÀ» ±â¹ÝÀ¸·Î ÇÑ ÄÚÆÃ Ã³¸®¸¦ ÇÑ ÀÇ·á¿ëÁö´Â ¹Ú¸®¼º°ú Åë±â¼ºÀ» À¯ÁöÇϸ鼭 ¹ÐÆó¼º°ú ³»½À¼ºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. ÀϺΠÀÇ·á¿ëÁö¿¡´Â Ç×±ÕÁ¦¸¦ ³»ÀåÇϰųª Áõ±â, ¿¡Æ¿·»¿Á»çÀ̵å, °¨¸¶¼±¿¡ ³ëÃâµÇ¸é º¯»öµÇ´Â ¸ê±Õ Ç¥½Ã±â¸¦ ÀμâÇÑ °Íµµ ÀÖ½À´Ï´Ù. ÀÌ´Â ¸ê±ÕÀ» Áõ¸íÇÒ »Ó¸¸ ¾Æ´Ï¶ó °ø±Þ¸Á¿¡ ÃßÀû¼º°ú °ËÁõÀ» Ãß°¡ÇÕ´Ï´Ù.

ÀÎ¼â ¹× °¡°ø ±â¼ú Çõ½ÅÀº ¼¶À¯ÀÇ ¹«°á¼º ¹× ¹«±Õ¼ºÀ» ¼Õ»ó½ÃŰÁö ¾Ê°í ±â°è ÆÇµ¶ÀÌ °¡´ÉÇÑ ¹ÙÄÚµå, ·ÎÆ® ¹øÈ£ ¹× ÄÄÇöóÀ̾𽺠½Éº¼À» ÅëÇÕÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. µðÁöÅÐ Àμ⠱â¼ú°ú À§Á¶ ¹æÁö À×Å©´Â À§Á¶¸¦ ¾ïÁ¦Çϰí ÁøÇ°¼ºÀ» º¸ÀåÇϱâ À§ÇØ µµÀԵǰí ÀÖ½À´Ï´Ù. ÀǾàǰ ¹× ÀÇ·á ±â¼ú »ý»ê¿¡¼­ Æ÷Àå ÀÚµ¿È­°¡ È®»êµÊ¿¡ µû¶ó °í¼Ó ½Ç¸µ ¶óÀÎ ¿ëÀ¸·Î ¼³°èµÈ ·Ñ ¿ëÁö ¹× ´ÙÀÌ ÄÆ ÀÇ·á ¿ëÁö´Â ÀÛ¾÷ È¿À²¼º¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù.

ÀÇ·á¿ëÁö ¼ö¿ä¸¦ ÁÖµµÇÏ´Â ÃÖÁ¾ »ç¿ë »ê¾÷ ¹× Áö¿ª ½ÃÀåÀº?

ÀÇ·á±â±â Á¦Á¶¾÷ü´Â ÀÇ·á¿ë Á¾ÀÌÀÇ °¡Àå Å« ¼ÒºñÃþÀ¸·Î, ÀÇ·á±â±â, ÀÓÇöõÆ®, ¼Ò¸ðǰ Æ÷Àå¿¡ ÀÇ·á¿ë Á¾À̸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ¼ö¼ú ŰƮ, Àúħ½À ±â±¸, ¸ê±Õ ºÎǰÀÇ º¸±ÞÀ¸·Î Á¾ÀÌ ¼Òºñ·®ÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º´¿ø°ú ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)µµ ÁÖ¿ä »ç¿ëÀÚÀ̸ç, ÇöÀå¿¡¼­ ±â±¸ÀÇ ¸ê±ÕÀ» À§ÇØ ½Å·ÚÇÒ ¼ö ÀÖ´Â Æ÷ÀåÁö ¹× ÆÄ¿ìÄ¡ Àç·á°¡ ÇÊ¿äÇÕ´Ï´Ù.

Á¦¾à¾÷°è¿¡¼­´Â ÀÇ·á¿ë Á¾À̰¡ ºí¸®½ºÅÍ Ä«µå ¶óº§¸µ, »ç¿ë ¼³¸í¼­, º¯Á¶ ¹æÁö ½Ç µî¿¡ »ç¿ëµË´Ï´Ù. Áø´Ü ½ÇÇè½Ç¿¡¼­´Â ÀÇ·á¿ë Á¾ÀÌ·Î ¸¸µç ½Ã·á ¿î¹Ý¿ë ÆÄ¿ìÄ¡ ¹× ¹«±Õ ½Ã·á ij¸®¾î¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÓ»ó½ÃÇè, ÇöÀå Áø´Ü, °¡Á¤¿ë °Ë»ç ŰƮ(COVID-19, ÀÓ½Å, Æ÷µµ´ç ¸ð´ÏÅ͸µ µî)´Â ¾ÈÀü¼º°ú »ç¿ë ÆíÀǼºÀ» À§ÇØ Á¾ÀÌ ±â¹Ý ¹«±Õ Æ÷Àå¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù.

Áö¿ªÀûÀ¸·Î´Â ºÏ¹Ì¿Í À¯·´ÀÌ ¾ö°ÝÇÑ ¸ê±Õ ÇÁ·ÎÅäÄÝ, ±ÔÁ¦ Áؼö Àǹ«, ÀÏȸ¿ë ÀÇ·áÁ¦Ç°ÀÇ º¸±ÞÀ¸·Î ÀÎÇØ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¼ö¼ú °Ç¼ö Áõ°¡, Àúºñ¿ë ÀÇ·á¿ë ÀÏȸ¿ëǰÀÇ ÇöÁö »ý»ê, º´¿ø ±â¹Ý È®´ë·Î ÀÎÇØ ±Þ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ Áß±¹°ú Àεµ´Â ÀÇ·á ¼Ò¸ðǰ ¼öÃâ Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Æ÷Àå ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÁøÇàÇϰí ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÀϺΠÁö¿ª¿¡¼­´Â ÀÇ·á Çö´ëÈ­ ¹× ÀåºñÀÇ ÇöÁö »ý»ê¿¡ µû¶ó ÀÇ·á¿ë Æ÷Àå ¼Ö·ç¼ÇÀÌ Ã¤Åõǰí ÀÖ½À´Ï´Ù.

¼¼°è ÀÇ·á¿ë Á¾ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¼¼°è ÀÇ·á¿ë Á¾ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº ¿Ü°ú¼ö¼ú Áõ°¡, ÀÏȸ¿ë ÀÇ·á±â±âÀÇ »ç¿ë È®´ë, Àü ¼¼°èÀÇ ¾ö°ÝÇÑ ¸ê±Õ ¿ä°Ç µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á½Ã¼³°ú ÀÇ·á Á¦Á¶¾÷üµéÀÌ ¹«±Õ¼º°ú ÃßÀû¼ºÀ» º¸ÀåÇϱâ À§ÇØ ÀÏȸ¿ë Æ÷Àå ÇüÅ·ΠÀüȯÇÔ¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ°í ±ÔÁ¤À» ÁؼöÇÏ´Â Á¾ÀÌ ±âÆÇ¿¡ ´ëÇÑ ¼ö¿ä°¡ ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

FDA, EU MDR, ISO µî ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã°¡ °­È­µÊ¿¡ µû¶ó ±â¾÷Àº À庮 ¹«°á¼º°ú ¹«±Õ¼ºÀ» º¸ÀåÇÏ´Â °í¼º´É Æ÷Àå¿¡ ÅõÀÚÇÒ ¼ö¹Û¿¡ ¾ø½À´Ï´Ù. ¼¶À¯ Á¶´Þ, ÄÚÆÃ ½Ã½ºÅÛ, Àμâ ÀûÇÕ¼º, ÀÚµ¿ ¹ÐºÀ, °í¼Ó º¯È¯, °¡º¯ ¸ê±Õ ȯ°æ¿¡ ¸Â´Â ¿ëÁö °³¹ßÀÌ °¡´ÉÇØÁø °ÍÀº ¼¶À¯ Á¶´Þ, ÄÚÆÃ ½Ã½ºÅÛ, Àμâ ÀûÇÕ¼º ºÐ¾ßÀÇ ±â¼ú ¹ßÀü ´öºÐÀÔ´Ï´Ù.

Áö¼Ó°¡´É¼ºµµ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖÀ¸¸ç, ÇÃ¶ó½ºÆ½ ±â¹Ý Çʸ§¿¡¼­ Àç»ýÇÑ ÀÚ¿øÀ¸·Î ¸¸µç ÀçȰ¿ë ¶Ç´Â ÅðºñÈ­ °¡´ÉÇÑ ÀÇ·á¿ë Á¾ÀÌ·Î ¼ö¿ä°¡ À̵¿Çϰí ÀÖ½À´Ï´Ù. HAI¸¦ ÁÙÀ̰í, ÀÇ·áÆó±â¹° °ü¸®¸¦ °³¼±Çϰí, ÀåºñÀÇ ÇöÁö »ý»êÀ» ÃËÁøÇϱâ À§ÇÑ Á¤ºÎÀÇ ±¸»óÀº »õ·Î¿î ½ÃÀå ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¿Ü·¡ ȯÀÚ Ä¡·á ¹× ÀçÅà Áø´Ü¿¡¼­ ÇöÀå Áï½Ã »ç¿ë °¡´ÉÇÑ °Ë»ç ŰƮ¿¡ À̸£±â±îÁö ÀÇ·á Á¦°ø ¸ðµ¨ÀÌ °è¼Ó ÁøÈ­ÇÔ¿¡ µû¶ó ¹«±Õ, ¾ÈÀüÇϰí Áö¼Ó°¡´ÉÇÑ Æ÷ÀåÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ÀÇ·á¿ë Á¾ÀÌÀÇ ¿ªÇÒÀº ±× ¹üÀ§¿Í Àü·«Àû Á߿伺ÀÌ ´õ¿í Ä¿Áú °ÍÀÔ´Ï´Ù.

ºÎ¹®

À¯Çüº°(ÄÚÆÃÁö, ºñÄÚÆÃÁö)£»Àç·áº°(Å©¶óÇÁÆ®Áö, »öÁö)£»ÃÖÁ¾»ç¿ëÀÚº°(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, Áø´Ü¡¤¿¬±¸ ¼¾ÅÍ ÃÖÁ¾»ç¿ëÀÚ, Á¦¾à ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

ºÐ¼® ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Grade Papers Market to Reach US$5.6 Billion by 2030

The global market for Medical Grade Papers estimated at US$4.7 Billion in the year 2024, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Coated Papers, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$3.8 Billion by the end of the analysis period. Growth in the Uncoated Papers segment is estimated at 1.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 5.9% CAGR

The Medical Grade Papers market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 5.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Medical Grade Papers Market - Key Trends & Drivers Summarized

Why Are Medical Grade Papers Gaining Strategic Importance Across Healthcare Applications?

Medical grade papers play a crucial role in sterile packaging, labeling, and documentation processes across hospitals, diagnostic labs, and medical device manufacturing environments. These papers are specifically engineered to withstand autoclaving, gamma radiation, and ethylene oxide sterilization while maintaining porosity, integrity, and barrier properties. They are primarily used in forming packaging materials for surgical instruments, wound care products, syringes, catheters, test kits, and single-use devices, ensuring sterility until the point of use.

Sterile barrier systems utilizing medical-grade papers help prevent microbial ingress and particulate contamination during storage and transportation of medical goods. Their compatibility with various sealing technologies-such as heat sealing, adhesive bonding, and ultrasonic welding-makes them indispensable in form-fill-seal packaging lines. In an era where healthcare-associated infections (HAIs) and contamination risks are under intense scrutiny, medical papers are being prioritized as foundational components of infection control protocols.

Which Technical Features and Innovations Are Enhancing the Performance of Medical Papers?

Advancements in paper chemistry, fiber technology, and coating formulations are significantly improving the performance characteristics of medical-grade papers. High-strength cellulose fibers, often blended with synthetic reinforcements, are being used to create tear-resistant, low-linting substrates that can endure sterilization cycles without delamination or discoloration. Manufacturers are optimizing basis weight, air permeability, and microbial barrier efficacy to ensure compliance with international standards such as EN 868, ISO 11607, and ASTM F88.

Coated medical papers-incorporating polyethylene, acrylate, or silicone-based formulations-offer improved sealing properties and moisture resistance while remaining peelable and breathable. Some medical papers are embedded with antimicrobial agents or printed with sterilization indicators that change color upon exposure to steam, ethylene oxide, or gamma rays. This not only validates sterilization but also adds traceability and verification to the supply chain.

Printing and converting innovations are allowing integration of machine-readable barcodes, lot numbers, and compliance symbols without compromising fiber integrity or sterility. Digital printing technologies and anti-counterfeiting inks are being deployed to deter tampering and ensure authenticity. As packaging automation becomes more prevalent in pharma and medtech production, roll-fed and die-cut medical papers designed for high-speed sealing lines are becoming critical to operational efficiency.

Which End-Use Industries and Geographic Markets Are Driving Demand for Medical Papers?

Medical device manufacturers represent the largest consumer segment for medical-grade papers, utilizing them in the packaging of instruments, implants, and disposables. The proliferation of single-use surgical kits, minimally invasive devices, and pre-sterilized components has significantly increased paper consumption. Hospitals and ambulatory surgical centers are also key users, where on-site sterilization of instruments demands reliable wrap papers and pouch materials.

The pharmaceutical industry uses medical-grade paper for blister card labeling, instruction leaflets, and tamper-evident seals. Diagnostic labs depend on specimen transfer pouches and sterile sample carriers made from medical-grade paper. Additionally, clinical trials, field diagnostics, and at-home test kits (e.g., COVID-19, pregnancy, glucose monitoring) rely on paper-based sterile packaging for safety and usability.

Geographically, North America and Europe dominate the market due to stringent sterilization protocols, regulatory compliance mandates, and widespread use of disposable medical products. The Asia-Pacific region is witnessing rapid growth driven by rising surgical volumes, local manufacturing of low-cost medical disposables, and an expanding hospital base. China and India, in particular, are investing in packaging infrastructure to meet growing exports of medical consumables. Latin America, the Middle East, and parts of Africa are adopting medical-grade packaging solutions in tandem with healthcare modernization and localized device production.

What Is Fueling Growth in the Medical Grade Papers Market Globally?

The growth in the global medical grade papers market is driven by several factors, including rising surgical procedures, expanded usage of single-use medical devices, and stringent global sterilization requirements. As healthcare facilities and medical manufacturers increasingly move toward disposable, pre-packaged formats to ensure sterility and traceability, the demand for reliable, regulatory-compliant paper substrates is expanding rapidly.

Increased regulatory scrutiny by bodies such as the FDA, EU MDR, and ISO is compelling companies to invest in high-performance packaging that guarantees barrier integrity and sterility assurance. Technological advancements in fiber sourcing, coating systems, and printability are enabling the development of papers tailored to automated sealing, high-speed converting, and variable sterilization environments.

Sustainability is also becoming a major driver, with demand shifting from plastic-based films to recyclable or compostable medical papers made from renewable resources. Government initiatives to reduce HAIs, improve medical waste management, and promote local device production are creating new market opportunities. With the continued evolution of healthcare delivery models-ranging from outpatient care and home diagnostics to field-ready testing kits-the role of medical-grade papers as an enabler of sterile, safe, and sustainable packaging will only grow in scope and strategic importance.

SCOPE OF STUDY:

The report analyzes the Medical Grade Papers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Coated Papers, Uncoated Papers); Material (Kraft Papers, Sack Papers); End-Use (Hospitals End-Use, Diagnostic & Research Centers End-Use, Pharmaceutical End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â